Metraipolis › archive › dc_d581a6ed27a7
Association Between Semaglutide or Tirzepatide Therapy and Residual Gastric Content: A Potential Danger During Upper Endoscopy — Europe PMC PMID:41393547
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41393547
- DOI
- 10.7759/cureus.96771
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T14:37:32.417Z
- SHA-256 of the archived text
b4c00391221672f054d8396b1238f48807586a4c04fea04380fa295684458382- Stable URL of this page
https://metraipolis.com/documento/dc_d581a6ed27a7
How to cite
Association Between Semaglutide or Tirzepatide Therapy and Residual Gastric Content: A Potential Danger During Upper Endoscopy — Europe PMC PMID:41393547 — Europe PMC (en), https://europepmc.org/article/MED/41393547 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d581a6ed27a7 (Metraipolis archive dc_d581a6ed27a7, sha256 b4c00391221672f054d8396b1238f48807586a4c04fea04380fa295684458382)
BibTeX
@misc{dcd581a6ed27a7,
title = {Association Between Semaglutide or Tirzepatide Therapy and Residual Gastric Content: A Potential Danger During Upper Endoscopy — Europe PMC PMID:41393547},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41393547},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d581a6ed27a7; sha256 b4c00391221672f054d8396b1238f48807586a4c04fea04380fa295684458382},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41393547. Agents can read the archived copy with the MCP tool read_document.